MedPath

To use Durvadi ghrita as a wound healing agent and as an alternative to povidone iodine in wound management

Phase 3
Conditions
Health Condition 1: L761- Accidental puncture and lacerationof skin and subcutaneous tissue during a procedure
Registration Number
CTRI/2023/01/048970
Lead Sponsor
Principal R.G.G.P.G ayurvedic college and hospital Paprola
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients willing for trial.

Patients of age group 16-70 years.

Patients with traumatic wounds and post-operative wounds.

Exclusion Criteria

Patients not willing for trial or not ready to give informed consent.

Patients with ischaemic wound.

Patients with Diabetes.

Patients with Tubercular diseases.

Patients with Fungal diseases.

Patients with Chronic skin diseases.

Patients with Malignancy.

Patients with Coagulopathy.

HIV positive patients

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To assess the effect of Durvadi Ghrita on pain, exudate, surrounding skin, wound bed, itching present over the wound and to compare its effect with that of Povidone IodineTimepoint: 4 weeks
Secondary Outcome Measures
NameTimeMethod
generate feeling of wellbeingTimepoint: 4 weeks
© Copyright 2025. All Rights Reserved by MedPath